Chester County News and Community Website
MALVERN, PA — Phlexglobal announced that Treximo, a leading life sciences consulting company and part of The Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as …
Read More
WASHINGTON, D.C. — As part of the U.S. Department of Veterans Affairs (VA) fight against the COVID-19 pandemic, the department announced its nationwide effort to recruit volunteers for COVID-19 clinical …
Read More MALVERN, PA — Phlexglobal, a leading innovative technology and services provider for the life sciences industry, recently announces that Hope Biosciences Stem Cell Research Foundation has selected Phlexglobal’s advanced SaaS …
Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced its financial results for the third quarter of …
Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced that, after a strategic review …
Read MoreThe U.S. Food and Drug Administration recently announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over …
Read More
MALVERN, PA — Phlexglobal announced the successful creation and implementation of the Global TMF Center of Excellence with partner PRA Health Sciences (NASDAQ: PRAH), one of the world’s leading global …
Read More
BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced dosing of the first …
Read More
As part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to …
Read More